Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

UroGen

Onco_background

Oncology Today—May 18, 2026

This week’s Oncology update highlights regulatory approvals, breakthrough…

by Ruairi McEntee

Onco_background

Oncology Weekly News - October 6th 2025

Oncology Update: Enhertu Superiority, Tecentriq Combo Approval, New Trials…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

Tags

AANAM Aging Research ATS 2025 Bavarian Nordic Bio-Thera Bone Marrow Transplant chronic urticaria Competitive Intelligence Tools Copper histidinate DB103 Dravet Syndrome Gut Brain Axis Haemonetics HER2-Positive Biliary Tract Cancer HIV prevention Lichen sclerosus LQ Ventures Menopausal Hormone Therapy Mexico MIRA Pharmaceuticals Oncology Research OTTAVA robotic surgical system pain management Parathyroid hormone–based therapies patient monitoring Patient Narrative pediatric rare diseases Penn Medicine Pociredir Postpartum Depression rare conditions Renal Denervation RNA RNA therapies ROCTAVIAN Royalty Pharma Sana Biotechnology Schizophrenia Research SciNeuro Sunlenca TAVI TULIP-SC Trial Type 3 Gaucher disease wearable health Wearable health technology

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

TAGS

AANAM Aging Research ATS 2025 Bavarian Nordic Bio-Thera Bone Marrow Transplant chronic urticaria Competitive Intelligence Tools Copper histidinate DB103 Dravet Syndrome Gut Brain Axis Haemonetics HER2-Positive Biliary Tract Cancer HIV prevention Lichen sclerosus LQ Ventures Menopausal Hormone Therapy Mexico MIRA Pharmaceuticals Oncology Research OTTAVA robotic surgical system pain management Parathyroid hormone–based therapies patient monitoring Patient Narrative pediatric rare diseases Penn Medicine Pociredir Postpartum Depression rare conditions Renal Denervation RNA RNA therapies ROCTAVIAN Royalty Pharma Sana Biotechnology Schizophrenia Research SciNeuro Sunlenca TAVI TULIP-SC Trial Type 3 Gaucher disease wearable health Wearable health technology

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy